Biopeak plans up to eight more preventive-health centres as India’s wellness market grows
Bengaluru-based Biopeak, which has raised nearly $11 million and operates two centres, aims to add 6-8 locations by early next year. Preventive-health peers including Ultrahuman, MetaGo, Cent Health and Nura are also expanding diagnostics-led offerings, though high capex and clinician dependence remain hurdles.
What happened
Indian preventive-health startups Biopeak, Ultrahuman, MetaGo, Cent Health and Nura are adding diagnostics and therapy centres as wellness spending rises, but
Key facts
- Biopeak raised nearly $11 million
- Biopeak plans 6-8 additional centres by early next year
- Biopeak has 2 operational centres and about 800 customers
- Nura has completed 82,000+ screenings
- Cent Health has completed 7,000 scans
- MetaGo has served 1,500 patients
- Biopeak centre build cost: $1.5-2 million
- Ultrahuman plans start at ₹10,000; Black membership costs ₹10 lakh annually
- Biopeak plans cost ₹1.1-1.3 lakh
- India health and wellness market: $164 billion in 2025, projected $257 billion by 2034
Why this matters
Biopeak’s expansion reinforces diagnostics-led preventive health as an active partnership and acquisition arena, with opportunities around clinic networks, testing infrastructure and clinician-led care platforms.
What to watch
- Whether Biopeak announces specific city locations, signed leases or centre-opening dates before early next year.
- Evidence of membership retention, repeat-test frequency and utilization levels at the first two centres.
- New fundraising, debt facilities or strategic hospital/diagnostic partnerships that finance expansion.
- Competitor moves by Ultrahuman, MetaGo, Cent Health and Nura into physical clinics, diagnostics networks or employer channels.
- Changes in preventive-testing regulation, physician availability, insurance reimbursement or corporate wellness budgets.
- Price reductions or aggressive bundling of blood tests, imaging, wearables and physician consultations.
- Prioritize Bengaluru, Mumbai, Delhi-NCR and Hyderabad micro-markets with dense affluent, insured and corporate populations.
- Build recurring revenue through annual health memberships, repeat testing protocols and longitudinal care plans rather than one-off diagnostic packages.
- Secure clinician capacity through equity incentives, medical advisory networks and partnerships with specialist hospitals.
- Pursue B2B2C distribution via employers, insurers, premium residential communities and fitness/wearable ecosystems.
- Standardize centre design, diagnostics workflows and care pathways to reduce payback periods on new locations.